Bryan Johnson reveals autoimmune gastritis diagnosis in quest to defy aging
Anti-aging advocate Bryan Johnson has revealed a diagnosis of autoimmune gastritis, marking a new challenge for his data-driven health project, Blueprint.
Bryan Johnson, the technology founder known for his high-profile efforts to reverse biological aging, has disclosed a diagnosis of autoimmune gastritis. The revelation, shared in a public post, highlights a medical challenge for an individual who has dedicated substantial personal wealth and resources to the pursuit of longevity and biological optimization.
Autoimmune gastritis involves the immune system mistakenly attacking the healthy cells in the stomach lining. According to reports, the condition carries risks including nutritional deficiency — specifically involving B12 and iron — as well as anemia and an elevated potential for cancer over time. Johnson indicated that the discovery of the condition occurred in May, though he stated he is uncertain how long the autoimmune process has been active within his body. It is estimated that 2–5% of the population may have the condition, with the possibility of a higher prevalence due to its tendency to remain undetected.
Media additions
In his communication regarding the diagnosis, Johnson attributed the origins of his health issues to lifestyle factors from his younger years. He described a history of consuming sugary cereals, soft drinks, and fast food during childhood. He further noted that the pressures of early fatherhood and the stress associated with building his business, which included founding the payments firm Braintree, led to a period where his health declined, resulting in weight gain and chronic depression. He suggests this timeline aligns with the onset of the autoimmune processes affecting his thyroid and stomach.
The standard medical consensus for autoimmune gastritis typically focuses on monitoring and managing symptoms rather than curative intervention. However, Johnson has expressed a determination to challenge this approach. He stated that his team intends to investigate potential solutions, arguing that many medical verdicts regarding incurable conditions are based on legacy science that has not kept pace with modern technological advancements, such as multiomics and cell-based therapies.
"In the age of AI, multiomics, and custom-built DNA, proteins, and cells, no condition should be presumed incurable simply because no one has yet tried to cure it with today’s stack."
Bryan Johnson, via Gizmodo
Johnson’s approach to health has previously drawn both intense public interest and criticism. His broader program, often referred to as Blueprint, involves rigorous health tracking, dietary protocols, and, in some instances, experimental procedures. These efforts have included monitoring blood markers and, at times, receiving blood transfusions from his son. Critics have frequently questioned the efficacy and necessity of these interventions, noting that some extreme practices may carry their own medical risks, such as the potential for graft-versus-host disease linked to blood transfusions, as referenced by the National Institutes of Health.
Despite these criticisms, Johnson maintains that his intensive health regimen has provided a protective buffer. He noted that without the interventions implemented over the past five years, his current health situation could have potentially become more serious. He views the diagnosis not as a failure of his anti-aging program, but as a validation of the necessity for constant vigilance and data-driven self-care.
As Johnson prepares to focus his resources on finding a solution for his autoimmune gastritis, he has reached out to the broader scientific community for collaboration. He has invited those with relevant expertise in autoimmune research to contact him, signaling a shift toward a more collaborative, albeit experimental, approach to addressing the disease.
What to watch next
- Research initiatives: Whether Johnson’s team produces peer-reviewed data or publishes internal findings regarding his attempts to reverse the condition.
- Protocol adjustments: Any changes to the specific supplements or dietary components of the Blueprint program in response to the autoimmune diagnosis.
- Public response: Continued discourse on the intersection of experimental lifestyle protocols and the clinical management of chronic illnesses.
The business and health technology communities continue to observe these developments closely. While standard medical advice remains centered on symptomatic management for this condition, Johnson’s pursuit of a cure represents a test of his core philosophy: that persistent, data-heavy technological intervention can overcome physiological limitations previously deemed immutable by modern medicine.
